Mikael Croyal

8PUBLICATIONS
52CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical molecular engineering of nucleic acids and proteinsInformation systems philosophy, research methods and theoryMajor global burdens of diseasePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 20, 2026
Methylglyoxal-glycated apolipoproteins A-I and A-II are associated with new-onset diabetes in individuals with prediabetes.

Chloé Chevalier, Arsênio Rodrigues Oliveira, Matthieu Wargny

|Apr 07, 2025
Methylglyoxal-Induced Glycation of Plasma Albumin: From Biomarker Discovery to Clinical Use for Prediction of New-Onset Diabetes in Individuals with Prediabetes.

Arsênio Rodrigues Oliveira, Chloé Chevalier, Matthieu Wargny

|Jun 06, 2023
Plasma Level of ATPase Inhibitory Factor 1 and Intrinsic Capacity in Community-Dwelling Older Adults: Prospective Data From the MAPT Study.

Jaqueline Aragoni da Silva, Laurent O Martinez, Yves Rolland

|Jun 23, 2022
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism.

Audrey Deprince, Nathalie Hennuyer, Sander Kooijman

|Oct 28, 2021
Perinatal Administration of C-Phycocyanin Protects Against Atherosclerosis in apoE-Deficient Mice by Modulating Cholesterol and Trimethylamine-N-Oxide Metabolisms.

Marine Coué, Mikael Croyal, Marina Habib

|Jul 27, 2021
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors.

Valentin Blanchard, Kévin Chemello, Tim Hollstein

Pageof 2

Frequent Collaborators

1 joint publications

Anne-Judith Waligora-Dupriet

1 joint publications

Moez Rhimi

1 joint publications

Corinne Grangette

1 joint publications

Emmanuelle Maguin